Similarly to the trend observed with AR expression, retrospective meta-analyses of patients with ER+ breast cancer have determined that high GR mRNA levels are associated with low tumour grade [148] and better prognosis [150,151] compared to low or negligible GR expression, independent of PR expression. The gene discussed is ESR1; the disease is neoplasm.